Company Quick10K Filing
Bio-Rad Laboratories
10-K 2020-12-31 Filed 2021-02-16
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-01
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-06
10-K 2013-12-31 Filed 2014-03-18
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-02-26
8-K 2020-10-29
8-K 2020-07-30
8-K 2020-05-21
8-K 2020-05-06
8-K 2020-04-28
8-K 2020-04-01
8-K 2020-02-25
8-K 2020-02-13
8-K 2019-12-05
8-K 2019-11-21
8-K 2019-10-31
8-K 2019-08-20
8-K 2019-08-01
8-K 2019-05-08
8-K 2019-05-02
8-K 2019-04-22
8-K 2019-04-15
8-K 2019-04-02
8-K 2019-03-19
8-K 2019-03-18
8-K 2019-02-28
8-K 2019-01-02
8-K 2018-12-04
8-K 2018-11-01
8-K 2018-08-07
8-K 2018-06-14
8-K 2018-05-08
8-K 2018-04-18
8-K 2018-03-19
8-K 2018-03-16
8-K 2018-02-27
8-K 2018-02-13

Bio-Rad Laboratories Financials

BIO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash614631907628670671574534456426463369367292332365385425413426450507458404419418456292322329384408404436434459583563
Accounts Receivable335369388389395375399388374376399378396383423384379354378342354342391381366368372373393420465430404382392392378356
Inventory370403398430449446434463449458448467485524501514521516471478501513490533542556525560581602595612591601584590590588
PP&E3063228128428758628829259389741,0121,0281,0321,0661,0871,1061,1301,0881,0891,0771,1091,1061,1171,1591,1791,2171,2271,2621,2781,2971,3051,3211,2891,2961,3271,3311,3491,347
Assets2,5272,6823,0632,9093,0442,9703,0973,1883,1693,3033,4373,4573,4833,2803,3893,4413,4683,3863,3413,3263,5253,6663,7123,7533,8754,0203,8513,9534,1434,1864,2736,2156,3866,7195,6116,8637,6477,177
Accounts Payable121113129110119113131119129132149131125127129122133135122
Long-Term Debt734734731732732732732732732733733733436436436436436436436436436436434434434434434434434435435439439439438438438
Liabilities1,2241,2541,5221,2951,3181,2761,3521,3481,3161,3681,4251,4261,4121,1561,2021,2091,2181,2091,1561,1281,1661,2371,2211,2091,2601,3171,2641,2451,3321,3371,3431,7271,7471,8181,5911,9992,1602,046
Stockholders' Equity1,2851,4241,5371,6121,7261,6931,7441,8401,8521,9352,0112,0312,0712,1242,1872,2332,2502,1772,1852,1992,3592,4302,4912,5442,6152,7032,5872,7072,8112,8482,9304,4884,6394,9004,0204,8645,4875,131
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue468472534485522517550486510499574500525505603509537531598473506470571471517509572500505535621552576545617554573561
Cost of Revenue199205234208229220239208223225260228225221280234240242281203227207262207237229257230231230276249274258284242265254
Gross Profit268266300278293296311279288274314271300284323275297289317270280263308264280279314270273305345302302287333312308307
R&D44434543484550535249605253535653565359474743564952505549636176494749485048
SG&A156149177168177177175171162160189186195202215202196203208189193187193190206201220195213197202209210201208201202
Tax-1713-1115371914252326141428181181711791185894-89-421122077281262171-76
Net Income39456833404659314942422035-730732123918281750121818-211252783657268269-828865599-259
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating6710020110517935747199201963736981834029398236-7775295-5662286940786243155100
Cash Investing-61-52-77-81-56-170-86-151-104-72-115-28180-42-39-63-39-49-28-28-27-84-51-59-53-50-110-37-15-13-19-84-30-23-15-110
Cash Financing3222-21512-2433434-32243324-032403331-1-343-2-22-16-4